Diagnostic and Prognostic Value of Lactate Threshold and pH - Threshold Determination during Cardiopulmonary Testing in Patients with Chronic Heart Failure
Tatiana A. Lelyavina, Maria Yu. Sitnikova, Eugeny V. Shlyakhto
Journal of Advances in Medicine and Medical Research · pp. 289–296 · Published 10 Sep 2014
10.9734/BJMMR/2015/12920Abstract
Objective: lactate threshold and pH-threshold determination during cardiopulmonary testing (CPET) and evaluate their diagnostic and prognostic value in patients with chronic heart failure. Methods: The study included 58 HF patients with NYHA class II-IV, who have performed CPET on treadmill using equipment «Oxycon PRO», Jaeger, Germany. Individual exercise test protocol (ramp protocol) was created for every participant. The cubital venous catheter was installed in all subjects before exercise test. Blood samples were taken at baseline and at 1-minute intervals during test. PH, lactate and HCO3- concentration were estimated using analyzer i-STAT, cartridge CG4 (Abbot, USA). Lactate threshold (LT) and pH-threshold (pH-T) were determined by changes in pH and lactate levels in correlation with dynamics of oxygen uptake (VO2), carbon dioxide output (VCO2), minute ventilation (VE), ventilatory equivalent of carbon dioxide (VE/VCO2), respiratory exchange ratio (RER). Respiratory compensation point (RCP) was determined, when ventilation dramatically increase relative VE/VCO2. Results: In HF patients with NYHA class II level of physical performance was significantly higher than in patients NYHA class III and IV. However, during exercise in all HF patients were observed similar physiological stages and compensatory mechanisms of regulation of homeostasis, but with varying of exercise intensity. In HF patient with NYHA class IV, exercise was stopped before reaching of RCP in connection with the development shortness of breath, weakness, tiredness, fatigue in the legs 8-9/10 Borg scale. Among HF patients with NYHA class III RCP reached 12 (36%) of people, among patients with class II - 14 (82%). The 95% confidence intervals (CI) for the VO2 peak, RCP, pH-T and LT in II, III and IV NYHA class are follows: in HF patients with NYHA class II - 17.4 to 18.2, 16.3 to 17.2, 14.7 to 15.3 and 9.7 to 10.1; NYHA class III - 13.5 to 14.3, 12.2 to 12.8, 11.4 to 11.8 and 8.2 to 8.6; NYHA class IV - 8.6 to 10.6 for VO2 peak, 8.1 to 9.7 for VO2 pH-T, 5.7 to 7.5 for VO2 LT. HF NYHA class correlated with VO2 LT, VO2 pH-T and VO2 RCP, r=-0.7, p<0.01, r=-0.5, p<0.01 and r=-0.4, p<0.01, respectively. Patients were observed in the average 21.4 of +/ - 1.5 months (6-48). For the specified period in the study group died 15 HF patients (25%) with III-IV FC. We observed the following correlations: the survival and VO2 LT - r=0.8, p<0.05; survival and VO2 Ñ€Ð-T - r=0.5, p<0.05; survival and VO2 RCP - r=0.2, p<0.07. Conclusion: In HF patients with NYHA class II-IV significant diagnostic and prognostic markers are content VO2 at lactate threshold and pH-threshold, especially at the lactate threshold.
Cited by 14
O. A. Ivanova, E. V. Ignatieva, T. A. Lelyavina · Russian Journal of Cardiology · 2020
Yashuang Hei, Lisi Ba, Ling Yu · Sensors and Actuators Reports · 2025
Yashuang Hei, Lisi Ba, Ling Yu · 2025
Tatiana Lelyavina, Victoria Galenko, Oksana Ivanova · International Journal of Molecular Sciences · 2019
M. A. Bortsova, E. A. Demchenko, A. E. Bautin · "Arterial’naya Gipertenziya" ("Arterial Hypertension") · 2020
Jian Liu, Lili Zhang, Chuanyun Fu · Analytical Methods · 2015
Yashuang Hei, Jing-ju Liu, Lisi Ba · 2025
Showing 7 of 14 known citations — external sources report more than can currently be individually listed.
Related research
- Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Risk: Retrospective Study of 50 Type 2 Diabetic Patients with Chronic Heart Failure — shares topic coverage
- Cardiac Cells in Regenerative Processes in Patients with Heart Failure Due to Ischaemic Heart Disease — shares topic coverage
- Heart Failure: A Rare Complication of Hypocalcemia — shares topic coverage
- Atrial Flutter Revealing Transthyretin Cardiac Amyloidosis : Diagnostic and Therapeutic Management – A Case Report and Literature Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
23
Page views
0
PDF downloads
0
Outbound clicks
14
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.